相似文献
1
Diabetes, COVID-19 and Mucormycosis: Unanswered Questions!糖尿病、新冠病毒肺炎与毛霉菌病：未解之谜！
Indian J Endocrinol Metab. 2021 May-Jun;25(3):191-192. doi: 10.4103/ijem.ijem_284_21. Epub 2021 Oct 26.
2
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病：全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
3
Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.与 COVID-19 大流行期间毛霉菌病流行相关的危险因素。
Int J Infect Dis. 2021 Oct;111:267-270. doi: 10.1016/j.ijid.2021.08.037. Epub 2021 Aug 24.
4
Rhinocerebral Mucormycosis and COVID-19 Pneumonia.鼻脑型毛霉菌病与新型冠状病毒肺炎
J Med Cases. 2021 Mar;12(3):85-89. doi: 10.14740/jmc3637. Epub 2021 Jan 19.
5
COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.COVID-19 和毛霉菌病综合征：印度崩溃的医疗体系面临的双重健康威胁。
Trop Med Int Health. 2021 Sep;26(9):1016-1018. doi: 10.1111/tmi.13641. Epub 2021 Jun 24.
6
Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit.在 COVID-19 特定的三级护理重症监护病房中，严格遵循方案驱动管理的情况下，（2020 年 3 月至 2021 年 5 月）未发生毛霉菌病病例。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102169. doi: 10.1016/j.dsx.2021.06.006. Epub 2021 Jun 9.
7
Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.COVID-19 相关的鼻眶脑毛霉菌病：一项系统性综述。
Indian J Pharmacol. 2021 Jul-Aug;53(4):317-327. doi: 10.4103/ijp.ijp_419_21.
8
Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.毛霉菌病：新冠大流行期间新的致命威胁
Mymensingh Med J. 2021 Jul;30(3):874-880.
9
Rhino-orbital Mucormycosis as a complication of severe COVID-19 pneumonia.鼻眶毛霉菌病作为重症新型冠状病毒肺炎的并发症
IDCases. 2021;26:e01293. doi: 10.1016/j.idcr.2021.e01293. Epub 2021 Sep 25.
10
Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series.印度一家三级护理医院的冠状病毒病相关毛霉菌病：病例系列
Cureus. 2021 Jul 3;13(7):e16152. doi: 10.7759/cureus.16152. eCollection 2021 Jul.
引用本文的文献
1
Effectiveness of facial palsy protocol among patient with mucormycosis following COVID-19: A case study.新型冠状病毒肺炎后毛霉菌病患者面神经麻痹治疗方案的有效性：一项病例研究
Heliyon. 2023 Feb;9(2):e13209. doi: 10.1016/j.heliyon.2023.e13209. Epub 2023 Jan 30.
本文引用的文献
1
Diagnosis and Management Considerations in Steroid-Related Hyperglycemia in COVID-19: A Position Statement from the Endocrine Society of India.新型冠状病毒肺炎中类固醇相关高血糖的诊断与管理考量：印度内分泌学会立场声明
Indian J Endocrinol Metab. 2021 Jan-Feb;25(1):4-11. doi: 10.4103/ijem.ijem_227_21. Epub 2021 Jul 21.
2
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病：全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
3
Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomes.在 COVID-19 大流行期间的糖尿病患病率、患者特征和不良结局。
Int J Clin Pract. 2021 Jul;75(7):e14112. doi: 10.1111/ijcp.14112. Epub 2021 Mar 14.
4
The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators.铁在 COVID-19 发病机制中的作用及乳铁蛋白和其他铁螯合剂的可能治疗作用。
Biomed Pharmacother. 2021 Apr;136:111228. doi: 10.1016/j.biopha.2021.111228. Epub 2021 Jan 13.
5
The Postmortem Features of Mucormycosis.毛霉菌病的尸检特征
Acad Forensic Pathol. 2020 Jun;10(2):72-80. doi: 10.1177/1925362120960918. Epub 2020 Nov 25.
6
Late onset infectious complications and safety of tocilizumab in the management of COVID-19.COVID-19 管理中托珠单抗的迟发性感染并发症和安全性。
J Med Virol. 2021 Mar;93(3):1459-1464. doi: 10.1002/jmv.26429. Epub 2020 Aug 21.
7
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
8
Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.COVID-19 患者合并症的患病率及其与死亡率的关系：系统评价和荟萃分析。
Diabetes Obes Metab. 2020 Oct;22(10):1915-1924. doi: 10.1111/dom.14124. Epub 2020 Jul 16.
9
Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019.2019冠状病毒病所致急性呼吸窘迫综合征长期使用皮质类固醇治疗的理论依据
Crit Care Explor. 2020 Apr 29;2(4):e0111. doi: 10.1097/CCE.0000000000000111. eCollection 2020 Apr.
10
Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review).锌与呼吸道感染：COVID-19 的展望（综述）。
Int J Mol Med. 2020 Jul;46(1):17-26. doi: 10.3892/ijmm.2020.4575. Epub 2020 Apr 14.
Zotero 插件